Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
2.65M
-
Shares change
-
-51.9K
-
Total reported value, excl. options
-
$827K
-
Value change
-
-$16.5K
-
Put/Call ratio
-
0.42
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$0.31
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2023
28 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2023.
IGC Pharma, Inc. - COM NEW (IGC) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.65M shares
.
Largest 10 shareholders include BlackRock Inc. (756K shares), VANGUARD GROUP INC (647K shares), GEODE CAPITAL MANAGEMENT, LLC (302K shares), STATE STREET CORP (184K shares), RENAISSANCE TECHNOLOGIES LLC (163K shares), DEARBORN PARTNERS LLC (117K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (75.2K shares), NORTHERN TRUST CORP (71.4K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (69K shares), and GOLDMAN SACHS GROUP INC (65.5K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.